-       Report 
- October 2025
-  189 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  194 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Report 
- February 2025
-  150 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- August 2025
-  151 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
          -       Report 
- May 2025
-  160 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
             -       Report 
- August 2024
-  150 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
          -       Report 
- February 2024
-  110 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- August 2024
-  181 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- October 2024
-  88 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
             Binders Excipients are a type of pharmaceutical intermediate used to bind active ingredients together in a tablet or capsule form. They are typically composed of natural or synthetic polymers, starches, cellulose derivatives, and other substances. Binders are used to improve the flowability of powders, reduce dusting, and improve the stability of the drug product. They also help to control the release of active ingredients, and can be used to modify the physical properties of the drug    product.
Binders Excipients are widely used in the pharmaceutical industry, and are available in a variety of forms, including granules, powders, and pastes. They are used in a variety of applications, including tablets, capsules, and other solid dosage forms.
Some companies in the Binders Excipients market include BASF, Roquette, Ashland, Colorcon, Dow, and Lubrizol. Show Less   Read more